Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06425471 · ClinicalTrials.gov registry record · NA

The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery

A NA study of In Utero Procedure Affecting Fetus or Newborn, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06425471 is a NA study of In Utero Procedure Affecting Fetus or Newborn that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06425471, a NA study of In Utero Procedure Affecting Fetus or Newborn, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery

Interventions

  • DEVICE KARL STORZ fetoscope arm

Study Locations (1)

Texas

  • The University of Texas health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-04-04
Est. Completion 2028-12-31
Phase NA

What the Registry Record Tells You About NCT06425471

The ClinicalTrials.gov registry entry for NCT06425471 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with In Utero Procedure Affecting Fetus or Newborn appearing as the primary indexed condition, and to 1 intervention - of which KARL STORZ fetoscope arm is the first listed.

NCT06425471 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06425471 about?

NCT06425471 is a clinical study titled "The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery". The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery

What is the current status of trial NCT06425471?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-04. Estimated completion is 2028-12-31.

What conditions does trial NCT06425471 study?

This clinical trial studies the following conditions: In Utero Procedure Affecting Fetus or Newborn.

What interventions are being tested in trial NCT06425471?

The interventions under investigation include: KARL STORZ fetoscope arm (DEVICE).

Who is sponsoring clinical trial NCT06425471?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06425471 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for In Utero Procedure Affecting Fetus or Newborn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.